10Feb
The LHD/ERISA Advisor: Sixth Circuit Rejects MSPA and ERISA Discrimination Claims
Seeking to control healthcare costs, many group health plans have adopted amendments that lower reimbursement rates for the treatment of end-stage renal disease ("ESRD"), which requires long-term dialysis treatment or a kidney transplant, resulting...
By:
Hinshaw & Culbertson LLP
Related
In July 2020, Quinn Emanuel achieved a favorable settlement for its client Advent International in t...
Read More >
Our comprehensive Guide to Doing Business in Australia, developed from the experience of our lawyers...
Read More >
On June 24, 2019, the Department of Labor made public its long-awaited proposed rule establishing a ...
Read More >
Surprisingly, in the midst of the COVID-19 emergency, final regulations under Section 901(m) were pu...
Read More >
Just before Christmas, the National Labor Relations Board (“NLRB”) evaluated two dress code polici...
Read More >
On September 16, 2019, the Federal Trade Commission (“FTC”) and the Antitrust Division of the Depa...
Read More >